Fig. 1

Dose dependent inhibition of S. commune HAE by plaque reduction assay: a Uninfected Vero cells, b Vero cells infected with DENV2 (NGC strain) (80–100 PFU), c Infected cell after treated with Ribavirin (250 μg/ml), d, e and f Infected cell after treated with S. commune HAE (2500 μg/ml, 1500 μg/ml and 500 μg/ml)